Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2−) advanced breast cancer patients: New insights beyond clinical trials. The EVA study

F. Cicchiello, F. Riva, M.E. Cazzaniga, F. Pedani, M. Nicolini, C. Butti, N. Liscia, C. Pogliani, G. Capri, M. Alù, A. Febbraro, L. Petrucelli, L. D'Onofrio, M. De Laurentiis, D. Pellegrini, L. Mentuccia, V. Cocciolone, E. Miraglio, E. Bajardi, M. DesterE. Paternò, G. Guaitoli, I. Ferrarini, E. Gervasi, L. Licata, C. Benedetto, D. Andreis, E. Bordin, C. Ancona, L. Pizzuti, V. Fotia, R. Berardi, M. Airoldi, V. Arcangeli, S. Artale, F. Atzori, A. Ballerio, G.V. Bianchi, L. Blasi, S. Campidoglio, M. Ciccarese, M.C. Cursano, M. Piezzo, A. Fabi, L. Ferrari, A. Ferzi, C. Ficorella, A. Frassoldati, A. Fumagalli, O. Garrone, V. Gebbia, D. Generali, N. La Verde, M. Maur, A. Michelotti, G. Moretti, A. Musolino, R. Palumbo, M. Pistelli, M. Porpiglia, D. Sartori, C. Scavelli, A. Schirone, A. Turletti, M.R. Valerio, P. Vici, A. Zambelli, L. Clivio, V. Torri

Research output: Contribution to journalArticle

Cite this

Cicchiello, F., Riva, F., Cazzaniga, M. E., Pedani, F., Nicolini, M., Butti, C., Liscia, N., Pogliani, C., Capri, G., Alù, M., Febbraro, A., Petrucelli, L., D'Onofrio, L., De Laurentiis, M., Pellegrini, D., Mentuccia, L., Cocciolone, V., Miraglio, E., Bajardi, E., ... Torri, V. (2017). Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2−) advanced breast cancer patients: New insights beyond clinical trials. The EVA study. Breast, 35, 115-121. https://doi.org/10.1016/j.breast.2017.06.043